PALO ALTO, CALIFORNIA / ACCESS Newswire / January 29, 2025 / Bioz, Inc., a cutting-edge innovator in AI-driven product ...

PALO ALTO, CALIFORNIA / ACCESS Newswire / January 29, 2025 / Bioz, Inc., a cutting-edge innovator in AI-driven product engagement and citation analytics, is excited to announce its successful integrat ...

Hera BioLabs has adopted Bioz's citation-driven badges to display real-time, evidence-based data on how their gene-editing products are being utilized in innovative scientific research. Featured ...

This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license.

Translation of human pluripotent stem cells into cell therapies will require the development of standardized tests for product consistency, stability, tumorigenicity, toxicity and immunogenicity ...

Introduction: Circulating tumor cells (CTCs) have attracted significant interest as a biomarker for cancer diagnosis. In this study, we judiciously constructed a recombinant MUC1-dependent adenovirus ...

Censavudine is under clinical development by Transposon Therapeutics and currently in Phase II for Progressive Supranuclear Palsy. According to GlobalData, Phase II drugs for Progressive Supranuclear ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. To address a wide range of genetic diseases, ...